Search Results

Congenica announces the appointment of Dr. Tom Barber as Chief Scientific Officer.

Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution.

Congenica to Provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project.

Congenica Receives CE Mark for Genomic Analysis Software Cambridge, United Kingdom.

Congenica , a digital health company enabling rapid analysis of complex genomic data, has launched an update for its clinical decision support platform that will provide automated classification, evidence and reporting of recurrent ‘known’ variants that customers observe in their rare disease cases, significantly saving time wh

Congenica, a digital health company enabling rapid and accurate analysis of complex genomic data, has launched a new module for its genomic analysis platform that will accelerate research into the relationship between an individual’s genomic variation and COVID-19 susceptibility, severity, and clinical outcomes.

Congenica Ltd, a digital health technology company enabling accelerated interpretation of complex genomic data to improve disease diagnosis, has announced significant developments to its software solution, with the integration of powerful new reference data sources, DECIPHER and Mastermind® into its clinical decision support platform.

Congenica Ltd, a pioneering digital health company enabling accelerated interpretation of complex genomic data to improve disease characterization and diagnosis, has announced the appointment of Dr Heiner Dreismann as non-executive Director and Senior Independent Director on the board.

Partnership will accelerate Congenica’s commercial expansion in the Chinese market

Congenica, the global diagnostic decision support platform provider, has announced that it now offers an on-premise deployment method in addition to cloud deployment for running its SapientiaTM platform.